# Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression

> **NCT04653337** · PHASE2 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Suicidal Ideation
- Depression

## Interventions

- **COMBINATION_PRODUCT:** Robot-assisted accelerated iTBS-1800 combined with serotonin-norepinephrine reuptake inhibitors(SNRIs)
- **COMBINATION_PRODUCT:** Robot-assisted accelerated iTBS-600 combined with serotonin-norepinephrine reuptake inhibitors(SNRIs)
- **COMBINATION_PRODUCT:** Sham accelerated iTBS combined with serotonin-norepinephrine reuptake inhibitors(SNRIs)

## Key facts

- **NCT ID:** NCT04653337
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-28
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04653337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04653337, "Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04653337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*